{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:56:31Z","timestamp":1790420191962,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":28,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662580806","type":"print"},{"value":"9783662580813","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/8904_2018_104","type":"book-chapter","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T23:03:40Z","timestamp":1524006220000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effectiveness of Early Hematopoietic Stem Cell Transplantation in Preventing Neurocognitive Decline in\u00a0Mucopolysaccharidosis Type II: A Case Series"],"prefix":"10.1007","author":[{"given":"A.","family":"Selvanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ellaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"issue":"3","key":"104_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"J Abbott","year":"2013","unstructured":"Abbott J (2013) Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36(3):437\u2013449","journal-title":"J Inherit Metab Dis"},{"issue":"13","key":"104_CR2","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","volume":"125","author":"M Aldenhoven","year":"2015","unstructured":"Aldenhoven M, Wynn R, Orchard P et al (2015) Long-term outcome of Hurler syndrome patients after hematopoietic stem cell transplantation: an international multicenter study. Blood 125(13):2164\u20132172","journal-title":"Blood"},{"issue":"3","key":"104_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ymgme.2009.05.006","volume":"98","author":"K Araya","year":"2009","unstructured":"Araya K, Sakai N, Mohri I et al (2009) Localized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantation. Mol Genet Metab 98(3):255\u2013263","journal-title":"Mol Genet Metab"},{"key":"104_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.bmt.1705718","volume":"40","author":"J Boelens","year":"2007","unstructured":"Boelens J, Wynn R, O\u2019Meara A et al (2007) Outcome of hematopoietic stem cell transplantation for Hurler\u2019s syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 40:225\u2013233","journal-title":"Bone Marrow Transplant"},{"key":"104_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pcl.2009.11.004","volume":"57","author":"J Boelens","year":"2010","unstructured":"Boelens J, Prasad V, Tolar J et al (2010) Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders. Pediatr Clin N Am 57:123\u2013145","journal-title":"Pediatr Clin N Am"},{"issue":"37","key":"104_CR6","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1073\/pnas.1205858109","volume":"109","author":"A Capotondo","year":"2012","unstructured":"Capotondo A, Milazzo R, Politi L et al (2012) Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation. Proc Natl Acad Sci U S A 109(37):15018\u201315023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"104_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-015-0356-0","volume":"10","author":"S Cho","year":"2015","unstructured":"Cho S, Lee J, Ko A et al (2015) Effect of systemic high dose enzyme replacement therapy on the improvement of CNS defects in a mouse model of mucopolysaccharidosis type II. Orphanet J Rare Dis 10:141\u2013152","journal-title":"Orphanet J Rare Dis"},{"key":"104_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-genom-090711-163739","volume":"13","author":"R Desnick","year":"2012","unstructured":"Desnick R, Schuchman E (2012) Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu Rev Genomics Hum Genet 13:307\u2013335","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"2","key":"104_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1590\/S1415-47572014000300003","volume":"37","author":"R Giugliani","year":"2014","unstructured":"Giugliani R, Villareal M, Valdez C et al (2014) Guidelines for diagnosis and treatment of Hunter syndrome for clinicians in Latin America. Genet Mol Biol 37(2):315\u2013329","journal-title":"Genet Mol Biol"},{"issue":"2","key":"104_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172435","volume":"12","author":"H Gleitz","year":"2017","unstructured":"Gleitz H, O\u2019Leary C, Holley R et al (2017) Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of mucopolysaccharidosis type II. PLoS One 12(2):e0172435","journal-title":"PLoS One"},{"key":"104_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","volume":"154","author":"N Guffon","year":"2009","unstructured":"Guffon N, Bertrand Y, Forest I et al (2009) Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. J Pediatr 154:733\u2013737","journal-title":"J Pediatr"},{"issue":"8249","key":"104_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","volume":"318","author":"J Hobbs","year":"1981","unstructured":"Hobbs J, Barrett A, Chambers D et al (1981) Reversal of clinical features of Hurler\u2019s disease and biochemical improvement after treatment by bone marrow transplantation. Lancet 318(8249):709\u2013712","journal-title":"Lancet"},{"key":"104_CR13","first-page":"104","volume":"10","author":"C Hunter","year":"1917","unstructured":"Hunter C (1917) A rare disease in two brothers. Proc R Soc Med 10:104\u2013116","journal-title":"Proc R Soc Med"},{"issue":"1\u20132","key":"104_CR14","first-page":"S77","volume":"120","author":"F Kubaski","year":"2017","unstructured":"Kubaski F, Suzuki Y, Yabe H et al (2017) Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis type II. Mol Genet Metab 120(1\u20132):S77","journal-title":"Mol Genet Metab"},{"issue":"8","key":"104_CR15","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/mt.2012.82","volume":"20","author":"A Langford-Smith","year":"2012","unstructured":"Langford-Smith A, Wilkinson F, Langford-Smith K et al (2012) Hematopoietic stem cell and gene therapy corrects primary neuropathology and behaviour in mucopolysaccharidosis IIIA mice. Mol Ther 20(8):1610\u20131621","journal-title":"Mol Ther"},{"key":"104_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","volume":"90","author":"J Muenzer","year":"2007","unstructured":"Muenzer J, Gucsavas-Calikoglu M, McCandless S et al (2007) A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 90:329\u2013337","journal-title":"Mol Genet Metab"},{"issue":"1","key":"104_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1542\/peds.2008-0416","volume":"123","author":"J Muenzer","year":"2009","unstructured":"Muenzer J, Wraith J, Clarke L et al (2009) Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123(1):19\u201329","journal-title":"Pediatrics"},{"issue":"1","key":"104_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/gim.2015.36","volume":"18","author":"J Muenzer","year":"2016","unstructured":"Muenzer J, Hendriksz C, Fan Z et al (2016) A phase I\/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II. Genet Med 18(1):73\u201381","journal-title":"Genet Med"},{"key":"104_CR20","first-page":"3421","volume-title":"The metabolic and molecular bases of inherited disease","author":"E Neufeld","year":"2001","unstructured":"Neufeld E, Menzer J (2001) The mucopolysaccharidoses. In: Scriver C, Beaudet A, Sly W, Valle D et al (eds) The metabolic and molecular bases of inherited disease, vol 3, 8th edn. McGraw-Hill, New York, pp 3421\u20133452","edition":"8"},{"key":"104_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ymgmr.2014.04.001","volume":"1","author":"P Patel","year":"2014","unstructured":"Patel P, Suzuki Y, Tanaka A et al (2014) Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome. Mol Genet Metab Rep 1:184\u2013196","journal-title":"Mol Genet Metab Rep"},{"issue":"5","key":"104_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ana.24246","volume":"76","author":"M Poe","year":"2014","unstructured":"Poe M, Chagnon S, Escolar M (2014) Early treatment is associated with improved cognition in Hurler syndrome. Ann Neurol 76(5):747\u2013753","journal-title":"Ann Neurol"},{"key":"104_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","volume":"107","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Okuyama T, Suzuki Y et al (2012) Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan. Mol Genet Metab 107:513\u2013520","journal-title":"Mol Genet Metab"},{"key":"104_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ymgme.2014.11.002","volume":"114","author":"J Tanjuakio","year":"2015","unstructured":"Tanjuakio J, Suzuki Y, Patel P et al (2015) Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation. Mol Genet Metab 114:161\u2013169","journal-title":"Mol Genet Metab"},{"issue":"4","key":"104_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1586\/17474086.2013.816507","volume":"6","author":"A Tichelli","year":"2013","unstructured":"Tichelli A, Rovo A (2013) Fertility issues following hematopoietic stem cell transplantation. Expert Rev Hematol 6(4):375\u2013388","journal-title":"Expert Rev Hematol"},{"key":"104_CR26","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1023\/A:1005525931994","volume":"22","author":"A Vellodi","year":"1999","unstructured":"Vellodi A, Young E, Cooper A (1999) Long-term follow-up following bone marrow transplantation for Hunter disease. J Inherit Metab Dis 22:638\u2013648","journal-title":"J Inherit Metab Dis"},{"key":"104_CR500","doi-asserted-by":"crossref","unstructured":"Wilkinson F, Sergijenko A, Langford-Smith K, Malinowski M, Wynn R, Bigger B (2013) Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation. Mol Ther 21(4):868\u2013876","DOI":"10.1038\/mt.2013.29"},{"key":"104_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","volume":"167","author":"J Wraith","year":"2008","unstructured":"Wraith J, Scarpa M, Beck M et al (2008) Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Paediatr 167:267\u2013277","journal-title":"Eur J Paediatr"},{"issue":"39","key":"104_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16390","volume":"16","author":"K Wyatt","year":"2012","unstructured":"Wyatt K, Henley W, Anderson L et al (2012) The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders. Health Technol Assess 16(39):1\u2013543","journal-title":"Health Technol Assess"}],"container-title":["JIMD Reports","JIMD Reports, Volume 41"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2018_104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:58:16Z","timestamp":1557485896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2018_104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783662580806","9783662580813"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/8904_2018_104","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"value":"2192-8304","type":"print"},{"value":"2192-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}